Organic disulfides
Medchemexpress LLC Luseogliflozin hydrate | 1152425-66-5 | MFCD34574461 | 99.2% | 452.56 | C23H32O7S | 5 MG
Luseogliflozin hydrate is the hydrated form of luseogliflozin, a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor used in preclinical and in vitro research on glucose transport and type 2 diabetes. The compound is supplied for laboratory research with accompanying analytical and safety documentation.
- Purity 99.2%.
- Molecular weight 452.56 g/mol.
- CAS number 1152425-66-5.
- Available as a solid powder in multiple pack sizes including 5 MG.
- Analytical data available: COA, HNMR, LCMS, SDS.
- Intended for preclinical and in vitro research use only.
Selleck Chemical LLC NX-2127-E1381-100MG
NX-2127 is a unique potent inhibitor of BTK that prevents its functions by catalyzing the ubiquitylation and proteasomal degradation of BTK rather than via direct binding NX-2127 stimulates T cell activation and increases IL-2 production in primary human T Cells
Selleck Chemical LLC NX-2127-E1381-5MG
NX-2127 is a unique potent inhibitor of BTK that prevents its functions by catalyzing the ubiquitylation and proteasomal degradation of BTK rather than via direct binding NX-2127 stimulates T cell activation and increases IL-2 production in primary human T Cells
Selleck Chemical LLC NX-2127-E1381-25MG
NX-2127 is a unique potent inhibitor of BTK that prevents its functions by catalyzing the ubiquitylation and proteasomal degradation of BTK rather than via direct binding NX-2127 stimulates T cell activation and increases IL-2 production in primary human T Cells
Medchemexpress LLC PROTAC degrader targeting Bruton's tyrosine kinase (BTK) | 2416131-46-7 | 99.7% | 719.83 | C39H45N9O5 | 10 MG
NX-2127 is an orally bioavailable PROTAC degrader that targets Bruton's tyrosine kinase (BTK). It induces proteasomal degradation of BTK, shows activity against BTK C481S resistance mutants, degrades IKZF1 and IKZF3 transcription factors, and has demonstrated cellular and in vivo preclinical activity while promoting T cell activation and IL-2 production.
- Orally bioavailable PROTAC degrader of BTK.
- Induces proteasomal degradation of BTK and reduces BTK signaling.
- Active against BTK C481S resistance mutants in cellular models.
- Degrades IKZF1 and IKZF3, providing immunomodulatory effects.
- Stimulates T cell activation and increases IL-2 production in primary human T cells.
- Demonstrated efficacy in preclinical in vivo models.
Chem-Impex International, Inc. 3-(2-Pyridyldithio)propionic acid N-hydroxyuccinimide ester | 68181-17-9 | MFCD00009636 | 250MG
3-(2-Pyridyldithio)propionic acid N-hydroxyuccinimide ester, 68181-17-9, MFCD00009636, 250MG
Chem-Impex International, Inc. 3-(2-Pyridyldithio)propionic acid N-hydroxyuccinimide ester | 68181-17-9 | MFCD00009636 | 100MG
3-(2-Pyridyldithio)propionic acid N-hydroxyuccinimide ester, 68181-17-9, MFCD00009636, 100MG
Medchemexpress LLC Dipropyl disulfide | 629-19-6 | MFCD00009378 | 99.3% | 150.31 g/mol | C6H14S2 | 1 G
Dipropyl disulfide is an organosulfur compound supplied as a high-purity research standard for biochemical and metabolic studies, analytical reference work, and assay development. It is offered in liquid and ready-to-use solution formats for convenient laboratory handling.
- High purity (99.3%).
- Molecular formula C6H14S2; molecular weight 150.31 g/mol.
- Available as 1 G liquid and larger pack sizes; also as 10 mM 1 mL in DMSO solutions.
- Storage: pure form -20°C (up to 3 years); in solvent -80°C (6 months).
- Suitable for metabolic studies and analytical reference use.
eMolecules Ambeed / N-Cyclohexyltaurine / 5g / 525245564 / A950389 / / 103-47-9 / MFCD00003835 / 207.290 / C8H17NO3S
Ambeed / N-Cyclohexyltaurine / 5g / 525245564 / A950389 / / 103-47-9 / MFCD00003835 / 207.290 / C8H17NO3S